1-2 of 2
Clementine Salvado, MD
Close
Sort by
Journal Articles

Yttrium-90 Ibritumomab Tiuxetan Is Feasible and Efficient in Unselected Patients. Definitive Results of a Large Retrospective Phase IV Study

Valentine Richez, Jr., MD, Julie Abraham, MD, Sandy Amorim, MD, Charles Herbaux, MD, Laure Philippe, MDcal student, Marc Andre, MD, Anne Parcelier, MD, Christophe Fruchart, MD, Krimo Bouabdallah, MD, Jérôme Cornillon, MD, Sigrid Cherrier, MD, Clementine Salvado, MD, Bernard Drenou, MD, Lucie Oberic, MD, Philippe Quittet, MD, Geoffroy Venton, MD, Claire Calmettes, MD, Safia Chebrek, MD, Cedric Rossi, MD, Arnaud Campidelli, MD, Bruno Lioure, MD, Sophie Auger, MD, Lucille Altounian, MD, Philippe Mineur, MD, Erwin Woff, MD, Frederic Peyrade, MD
Journal: Blood
Blood (2015) 126 (23): 5108.
https://doi.org/10.1182/blood.V126.23.5108.5108
Published: 2015
Journal Articles

HLA-Matched Related Donor Hematopoietic Cell Transplantation in Patients with Fanconi Anemia Conditioned with a Combination of Cyclophosphamide and Fludarabine : A Study on Behalf of the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)

Lina Benajiba, MD, Clementine Salvado, MD, Jean-Hugues Dalle, MD PhD, Charlotte Jubert, MD, Claire Galambrun, MD, Jean Soulier, MD PhD, Gerard Socie, MD PhD, Regis Peffault de Latour, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4391.
https://doi.org/10.1182/blood.V124.21.4391.4391
Published: 2014